Seng Gee Lim

Active 1993–2025

107
Papers
21,735
Citations
71
h-index
103
i10-index

Citations

Citations per year for Seng Gee Lim1966: 1 citations1979: 1 citations1995: 6 citations1996: 2 citations1997: 2 citations1998: 6 citations1999: 7 citations2000: 4 citations2001: 13 citations2002: 12 citations2003: 61 citations2004: 81 citations2005: 112 citations2006: 101 citations2007: 144 citations2008: 121 citations2009: 142 citations2010: 110 citations2011: 132 citations2012: 158 citations2013: 100 citations2014: 149 citations2015: 134 citations2016: 122 citations2017: 136 citations2018: 129 citations2019: 526 citations2020: 703 citations2021: 762 citations2022: 525 citations2023: 396 citations2024: 727 citations2025: 293 citations2026: 8 citations1967–1978: no citations, so these years are not shown1980–1994: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,504 citing papers, 17.3% of this breakdownChina: 1,469 citing papers, 16.9% of this breakdownUnited Kingdom: 404 citing papers, 4.7% of this breakdownGermany: 370 citing papers, 4.3% of this breakdownTaiwan: 346 citing papers, 4% of this breakdownFrance: 331 citing papers, 3.8% of this breakdownSouth Korea: 307 citing papers, 3.5% of this breakdownItaly: 299 citing papers, 3.4% of this breakdownJapan: 297 citing papers, 3.4% of this breakdownSingapore: 269 citing papers, 3.1% of this breakdownCanada: 267 citing papers, 3.1% of this breakdownIndia: 261 citing papers, 3% of this breakdown
0%17.3%Other 29.5%

Fields

  • Medicine81.5%
  • Biochemistry, Genetics and Molecular Biology8.8%
  • Immunology and Microbiology4.9%
  • Pharmacology, Toxicology and Pharmaceutics1.9%
  • Agricultural and Biological Sciences0.7%
  • Engineering0.4%
  • Other1.8%

Topics

  • Hepatitis B Virus Studies13.8%
  • Hepatitis C virus research11.8%
  • Liver Disease Diagnosis and Treatment10.3%
  • Hepatitis Viruses Studies and Epidemiology4.5%
  • Liver Disease and Transplantation4.5%
  • Hepatocellular Carcinoma Treatment and Prognosis3.7%
  • Other51.4%

Coauthors

All papers

Open in search
  1. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Man‐Fung Yuen, Shu Zheng, Jia‐Horng Kao - Hepatology International 2015 cited by 2,564

  2. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Omesh Goyal, Hasmik Ghazinyan, Anil Arora, Jinhua Hu, Manoj Kumar Sahu, Padaki Nagaraja Rao, Guan Huei Lee, Seng Gee Lim, Laurentius A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, V. G. Mohan Prasad, Diana A. Payawal, Zaigham Abbas, A. Kadir Dökmeci, Jose D. Sollano, Gian Carpio, Ananta Shresta, George Lau, Md. Fazal Karim, Gamal Shiha, Rino Alvani Gani, Kemal Fariz Kalista, Man‐Fung Yuen, Bikrant Bihari Lal, Rajeev Khanna, Vikrant Sood, Bikrant Bihari Lal, Viniyendra Pamecha, Ankur Jindal, V. Rajan, Vinod Arora, Osamu Yokosuka, Madunil Anuk Niriella, Hai Li, Xiaolong Qi, Atsushi Tanaka, Satoshi Mochida, Dominic Ray Chaudhuri, Ed Gane, Khin Maung Win, Wei Ting Chen, M Rela, Dharmesh Kapoor, Amit Rastogi, Pratibha Kale, Archana Rastogi, Chhagan Bihari Sharma, Meenu Bajpai, Virender Singh, Madhumita Premkumar, Sudhir Maharashi, A. Olithselvan, Cyriac Abby Philips, Anshu Srivastava, Surender Kumar Yachha, Zeeshan Ahmad Wani, B. R. Thapa, Anoop Saraya, S. Shalimar, Ashish Kumar, Manav Wadhawan, Subash Gupta, Kaushal Madan, Puja Sakhuja, Vivek Vij, Barjesh Chander Sharma, Hitendra Garg, Vishal Garg, Chetan Kalal and 12 more - Hepatology International 2019 cited by 889

  3. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

    Authors: , , , , , , , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 524

  4. Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helene Plein, Fiona Campbell, Melanie Paff, Dickens Theodore - New England Journal of Medicine 2022 cited by 252

  5. A global scientific strategy to cure hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui‐Cheol Shin, Alexander Thompson, Florian van Bömmel, Fusheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man‐Fung Yuen, Timothy M. Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi, Fabien Zoulim - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 495

  6. The scientific basis of combination therapy for chronic hepatitis B functional cure

    Authors: , , , , , , , , - Nature Reviews Gastroenterology & Hepatology 2023 cited by 156

  7. Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2021 cited by 136

  8. Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ramsey Cheung, Seng Gee Lim, Huy N. Trinh, Wan‐Long Chuang, Yasuhito Tanaka, Hidenori Toyoda, Ming‐Lung Yu, Mindie H. Nguyen - Hepatology 2023 cited by 89

  9. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk

    Authors: , , , , , , , , , , , - Gastroenterology 2015 cited by 550

  10. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    Authors: , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2015 cited by 291

  11. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Gut 2018 cited by 207

  12. CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Immunology 2020 cited by 97

  13. CpG-Adjuvanted Hepatitis B Vaccine (HEPLISAV-B®) Update

    Authors: , - Expert Review of Vaccines 2021 cited by 99

  14. Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , L.A. Lesmana, Cosmas Rinaldi Adithya Lesmana, Samir Shah, Chetan Kalal, Zaigham Abbas, Jose D. Sollano, V. G. Mohan Prasad, Diana Payawal, A. Kadir Dökmeci, Padaki Nagaraja Rao, Ananta Shrestha, George Lau, Man‐Fung Yuen, Vivek A. Saraswat, Gamal Shiha, Osamu Yokosuka, Chandan Kumar Kedarisetty, Priyanka Jain, P. Bhatia, Shiv Kumar Sarin, for the APASL ACLF working party - The American Journal of Gastroenterology 2019 cited by 83

  15. Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2015 cited by 338

  16. Outcomes of Long-term Treatment of Chronic HBV Infection With Entecavir or Other Agents From a Randomized Trial in 24 Countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tao Han, Yanyan Ji, Junqi Niu, Jian Sun, Yongpeng Chen, Elizabeth Cooney, Seng Gee Lim - Clinical Gastroenterology and Hepatology 2019 cited by 112

  17. Hepatitis B virus–specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 209

  18. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hamsik GHaziuan, Nizar N. Zein, Manoj Kumar - Hepatology International 2016 cited by 235

  19. Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Liver International 2021 cited by 59

  20. Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Melanie Paff, Dickens Theodore - Journal of Hepatology 2022 cited by 55

  21. Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines

    Authors: , , , , , , , , , , - Journal of Hepatology 2010 cited by 214

  22. Analysis and Validation of Human Targets and Treatments Using a Hepatocellular Carcinoma–Immune Humanized Mouse Model

    Authors: , , , , , , , , , , , , , , , , - Hepatology 2021 cited by 50

  23. Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT

    Authors: , , , , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 47

  24. Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of Nonalcoholic Steatohepatitis between Males and Females

    Authors: , , , , , , , , , , , , , , , , , - Digestive Diseases 2023 cited by 32